The male pill? trial tests new daily contraceptive for men
NCT ID NCT06542237
Summary
This study is testing a new daily pill called YCT-529 for male contraception. It aims to see if the pill is safe, how the body processes it, and how it affects hormones and sexual function. The study will enroll 88 healthy men who have decided not to father children and will give them the pill for 28, 90, or 180 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALE CONTRACEPTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research (NZCR)
RECRUITINGGrafton, Auckland, 1010, New Zealand
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.